Antimicrobial Efficacy of Cubic, Single-Leaf, and Flower-like Zeolitic Imidazolate Frameworks
Source abstract
Abstract
Zeolite imidazolate frameworks (ZIFs) have been widely used in drug delivery and antibacterial applications due to their highly controllable structure and pore size. However, the relationship between the structure of ZIFs and their antibacterial efficacy has not been fully elucidated. In this study, three ZIFs with uniform sizes and specific morphologies were synthesized: cubic (Z-8), leaf-like (Z-L), and flower-like (FZ-L). Flow cytometry was employed to assess the effects of these materials on Bacillus subtilis and Escherichia coli at different concentrations and exposure times. Results showed that sharp-edged ZIFs possess enhanced antibacterial effects. Specifically, FZ-L exhibited the lowest minimum inhibitory concentration of 400 μg/mL and a minimum bactericidal concentration of 20 μg/mL, which can kill bacteria effectively and rapidly. Further study on the antibacterial mechanisms showed that these materials do not produce reactive oxygen species (ROS) themselves but induce ROS production in bacteria and accelerate bacterial death. Biocompatibility studies suggested that ZIFs have minimal toxicity to human cells, indicating their potential in biomedical applications. This research provides insights into the antibacterial mechanisms of ZIFs, which can support their development for antimicrobial use.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Medicinal Plants and Neuroprotection · Nanocomposite Films for Food Packaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Biotechnology and Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, Jiangnan University, Wuxi 214122, China
Department of Urology, Jiangnan University Medical Center (Wuxi No. 2 People’s Hospital), Wuxi 214000, China
Funding
National Key Research and Development Program of China · Wuxi Health and Family Planning Commission · National Natural Science Foundation of China
References (62)
Show source-provided references
1. 10.1016/j.talanta.2022.12383310.1016/j.talanta.2022.123833 ↗
2. 10.1016/j.bios.2024.11604610.1016/j.bios.2024.116046 ↗
3. 10.1021/acs.analchem.3c0568210.1021/acs.analchem.3c05682 ↗
4. 10.1016/j.biomaterials.2016.10.04110.1016/j.biomaterials.2016.10.041 ↗
5. 10.1016/j.bioactmat.2022.01.03610.1016/j.bioactmat.2022.01.036 ↗
6. 10.1021/acsanm.3c0506010.1021/acsanm.3c05060 ↗
7. 10.1021/acs.analchem.1c0128010.1021/acs.analchem.1c01280 ↗
8. 10.1002/anie.20221734510.1002/anie.202217345 ↗
9. 10.1021/acsami.2c1341510.1021/acsami.2c13415 ↗
10. 10.1016/j.snb.2021.13034510.1016/j.snb.2021.130345 ↗
11. 10.1007/s12274-020-3146-510.1007/s12274-020-3146-5 ↗
12. 10.1021/acsnano.7b0203510.1021/acsnano.7b02035 ↗
13. 10.1016/j.nantod.2023.10187510.1016/j.nantod.2023.101875 ↗
14. 10.1016/j.cclet.2022.06.07310.1016/j.cclet.2022.06.073 ↗
15. 10.1002/advs.20230715410.1002/advs.202307154 ↗
16. 10.1016/j.colcom.2018.08.00210.1016/j.colcom.2018.08.002 ↗
17. 10.1039/C8CY00078F10.1039/C8CY00078F ↗
18. 10.1016/j.jece.2022.10855810.1016/j.jece.2022.108558 ↗
19. 10.1039/C9NR03797G10.1039/C9NR03797G ↗
20. 10.1016/j.memsci.2019.11777310.1016/j.memsci.2019.117773 ↗
21. 10.1021/jacs.6b0024310.1021/jacs.6b00243 ↗
22. 10.1007/s40820-022-00826-410.1007/s40820-022-00826-4 ↗
23. 10.1021/acs.langmuir.8b0026210.1021/acs.langmuir.8b00262 ↗
24. 10.1038/s41467-020-15471-x10.1038/s41467-020-15471-x ↗
25. 10.1016/j.cis.2019.10206310.1016/j.cis.2019.102063 ↗
26. 10.1021/acsnano.8b0895910.1021/acsnano.8b08959 ↗
27. 10.1021/acsanm.4c0102910.1021/acsanm.4c01029 ↗
28. 10.1016/j.cclet.2024.10983510.1016/j.cclet.2024.109835 ↗
29. 10.1039/C7NR03739B10.1039/C7NR03739B ↗
30. 10.1021/acssuschemeng.1c0148810.1021/acssuschemeng.1c01488 ↗
31. 10.1016/j.apmt.2022.10143010.1016/j.apmt.2022.101430 ↗
32. 10.3390/cryst1304056410.3390/cryst13040564 ↗
33. 10.3389/fbioe.2022.102674310.3389/fbioe.2022.1026743 ↗
34. 10.1039/D4NA00142G10.1039/D4NA00142G ↗
35. 10.3390/ijms2314751010.3390/ijms23147510 ↗
36. 10.1039/C8NH00113H10.1039/C8NH00113H ↗
37. 10.1021/acsanm.2c0100310.1021/acsanm.2c01003 ↗
38. 10.1016/j.ecoenv.2020.11111010.1016/j.ecoenv.2020.111110 ↗
39. 10.1016/j.ica.2022.12111010.1016/j.ica.2022.121110 ↗
40. 10.1021/acsanm.3c0440010.1021/acsanm.3c04400 ↗
41. 10.1039/C9CE00833K10.1039/C9CE00833K ↗
42. 10.1039/C8TA10249J10.1039/C8TA10249J ↗
43. 10.1016/j.molliq.2017.12.00510.1016/j.molliq.2017.12.005 ↗
44. 10.1002/smll.20220568210.1002/smll.202205682 ↗
45. 10.1021/acsanm.4c0303410.1021/acsanm.4c03034 ↗
46. 10.1016/j.cej.2022.13679210.1016/j.cej.2022.136792 ↗
47. 10.1021/acsinfecdis.2c0049610.1021/acsinfecdis.2c00496 ↗
48. 10.1021/acsanm.3c0244310.1021/acsanm.3c02443 ↗
49. 10.1021/acsanm.4c0239310.1021/acsanm.4c02393 ↗
50. 10.1016/j.cej.2020.12751110.1016/j.cej.2020.127511 ↗
51. 10.1021/acs.analchem.3c0284110.1021/acs.analchem.3c02841 ↗
52. 10.1039/D0NR03809A10.1039/D0NR03809A ↗
53. 10.3390/nano1301020210.3390/nano13010202 ↗
54. 10.1039/D3NR05458F10.1039/D3NR05458F ↗
55. 10.1016/j.cej.2023.14320110.1016/j.cej.2023.143201 ↗
56. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
57. 10.1021/acsnano.2c0959310.1021/acsnano.2c09593 ↗
58. 10.1021/acsami.8b0124510.1021/acsami.8b01245 ↗
59. 10.1016/j.actbio.2023.03.03010.1016/j.actbio.2023.03.030 ↗
60. 10.1021/acs.biomac.3c0106010.1021/acs.biomac.3c01060 ↗
61. 10.1002/advs.20230709410.1002/advs.202307094 ↗
62. 10.1002/smll.20230722010.1002/smll.202307220 ↗